Evidence map›Paper›PMID 28045579›Full record

ReviewGut microbes2017

Gut microbiota as a source of a surrogate antigen that triggers autoimmunity in an immune privileged site.

Carlos R Zárate-Bladés, Reiko Horai, Mary J Mattapallil, Nadim J Ajami, Matthew Wong, Joseph F Petrosino, Kikuji Itoh, Chi-Chao Chan, Rachel R Caspi

Open access · goldAbstract readReview
In one paragraph

Review in Gut microbes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Gut microbiota and eye diseases: a bibliometric study and visualization analysis.Frontiers in cellular and infection microbiology · 2023
    Article
  17. Microbiome in Immune-Mediated Uveitis.International journal of molecular sciences · 2022
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Carlos R Zárate-Bladésa Laboratory of Immunology , National Eye Institute, National Institutes of Health , Bethesda , Maryland , USA.
Reiko Horaia Laboratory of Immunology , National Eye Institute, National Institutes of Health , Bethesda , Maryland , USA.
Mary J Mattapallila Laboratory of Immunology , National Eye Institute, National Institutes of Health , Bethesda , Maryland , USA.
Nadim J Ajamic Alkek Center for Metagenomics and Microbiome Research and Department of Molecular Virology and Microbiology , Baylor College of Medicine , Houston , Texas , USA.
Matthew Wongc Alkek Center for Metagenomics and Microbiome Research and Department of Molecular Virology and Microbiology , Baylor College of Medicine , Houston , Texas , USA.
Joseph F Petrosinoc Alkek Center for Metagenomics and Microbiome Research and Department of Molecular Virology and Microbiology , Baylor College of Medicine , Houston , Texas , USA.
Kikuji Itohd Bio-Technical Center, Japan SLC, Inc. , Hamamatsu , Shizuoka , Japan.
Chi-Chao Chana Laboratory of Immunology , National Eye Institute, National Institutes of Health , Bethesda , Maryland , USA.
Rachel R Caspia Laboratory of Immunology , National Eye Institute, National Institutes of Health , Bethesda , Maryland , USA.
National Institutes of Health · USBaylor College of Medicine · US

Funding

Genetic, Cellular and Molecular Mechanisms in Autoimmunity to RetinaZIAEY000184 · NEI · NATIONAL EYE INSTITUTE · PI CASPI, RACHEL R. · 2009 to 2025
$51.7M
Flow Cytometry COREZICEY000457 · NEI · NATIONAL EYE INSTITUTE · PI CASPI, RACHEL R. · 2009 to 2025
$5.9M
6 · The paper itself

Abstract

Recent discoveries on the role of commensal microbiota have significantly changed our understanding of human physiology. The host-microbiota interplay is now an important aspect to take into account to understand immune responses and immunological diseases. Autoimmune uveitis is a sight-threatening disease that arises without a known infectious etiology. It is unknown where and how autoreactive T cells become primed to trigger disease in the eye, which is an immune privileged site. We recently reported data supporting the notion that retina-specific T cells receive a signal in the gut from commensal microbiota-derived cross-reactive antigen(s) and trigger autoimmune uveitis in the R161H mouse model. Here we discuss our published findings, as well as our recent attempts to identify the responsible microbe(s) by using different antibiotic treatments, 16S rDNA sequencing and homology searches for candidate antigenic mimic(s) of the retinal antigen.

Indexed as

Gastrointestinal MicrobiomeAnimalsAntigensAutoimmune DiseasesAutoimmunityHumansRetinaT-LymphocytesUveitisAntigensautoimmune uveitisimmune privilegeinterphotoreceptor retinoid-binding protein (IRBP)microbiotaretinaT cell

Identifiers

PMID28045579
PMCPMC5361604
OpenAlexW2567043679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.